Go Ad-Free
    My Alerts
    Moneycontrol
    Moneycontrol PRO
    HomeNewsZyduslifesciences

    Jump to

    • Cadila: a formidable play in Covid times and beyond

      Cadila is not only a credible Indian pharma striving for a Covid solution, but on a longer time scale is an interesting watch in the large-cap space witnessing a significant transformation in product portfolio.

    • Reduce Cadila Healthcare; target of Rs 408: Dolat Capital

      Dolat Capital recommended reduce rating on Cadila Healthcare with a target price of Rs 408 in its research report dated August 14, 2020.

    • Buy Cadila Healthcare; target of Rs 470: ICICI Direct

      ICICI Direct is bullish on Cadila Healthcare has recommended buy rating on the stock with a target price of Rs 470 in its research report dated August 06, 2020.

    • Reduce Cadila Healthcare; target of Rs 408: Dolat Capital

      Dolat Capital recommended accumulate rating on Cadila Healthcare with a target price of Rs 408 in its research report dated August 05, 2020.

    • Hold Cadila Healthcare; target of Rs 402: Emkay Global Financial

      Emkay Global Financial recommended hold rating on Cadila Healthcare with a target price of Rs 402 in its research report dated August 05, 2020.

    • Sell Cadila Healthcare; target of Rs 329: Prabhudas Lilladher

      Prabhudas Lilladher is bearish on Cadila Healthcare has recommended sell rating on the stock with a target price of Rs 329 in its research report dated August 06, 2020.

    • Hold Cadila Healthcare; target of Rs 445: Sharekhan

      Sharekhan recommended Hold rating on Cadila Healthcare with a target price of Rs 445 in its research report dated August 05, 2020.

    • Buy Cadila Healthcare; target of Rs 460: Motilal Oswal

      Motilal Oswal is bullish on Cadila Healthcare recommended buy rating on the stock with a target price of Rs 460 in its research report dated August 06, 2020.

    • Buy Cadila Healthcare; target of Rs 420: ICICI Direct

      ICICI Direct is bullish on Cadila Healthcare has recommended buy rating on the stock with a target price of Rs 420 in its research report dated June 22, 2020.

    • Buy Cadila Healthcare; target of Rs 420: Motilal Oswal

      Motilal Oswal is bullish on Cadila Healthcare has recommended buy rating on the stock with a target price of Rs 420 in its research report dated June 20, 2020.

    • Hold Cadila Healthcare: target of Rs 380: Sharekhan

      Sharekhan recommended Hold rating on Cadila Healthcare with a target price of Rs 380 in its research report dated June 19, 2020.

    • Pharma companies that can benefit from the demand for complex respiratory drugs

    • Hold Cadila Healthcare; target of Rs 285: ICICI Direct

      ICICI Direct recommended hold rating on Cadila Healthcare with a target price of Rs 285 in its research report dated February 10, 2020.

    • Hold Cadila Healthcare; target of Rs 247: Prabhudas Lilladher

      Prabhudas Lilladher recommended hold rating on Cadila Healthcare with a target price of Rs 247 in its research report dated February 06, 2020.

    • Hold Cadila Healthcare; target of Rs 220: Prabhudas Lilladher

      Prabhudas Lilladher recommended Hold rating on Cadila Healthcare with a target price of Rs 220 in its research report dated November 13, 2019.

    • Hold Cadila Healthcare target of Rs 275: Sharekhan

      Sharekhan recommended Hold rating on Cadila Healthcare with a target price of Rs 275 in its research report dated November 14, 2019.

    • Hold Cadila Healthcare; target of Rs 260: ICICI Direct

      ICICI Direct recommended hold rating on Cadila Healthcare with a target price of Rs 260 in its research report dated November 14, 2019.

    • Hold Cadila Healthcare; target of Rs 275: Sharekhan

      Sharekhan recommended Hold rating on Cadila Healthcare with a target price of Rs 275 in its research report dated August 09, 2019.

    • Buy Cadila Healthcare; target of Rs 265: HDFC Securities

      HDFC Securities is bullish on Cadila Healthcare has recommended buy rating on the stock with a target price of Rs 265 in its research report dated August 10, 2019.

    • Hold Cadila Healthcare; target of Rs 250: ICICI Direct

      ICICI Direct recommended hold rating on Cadila Healthcare with a target price of Rs 250 in its research report dated August 12, 2019.

    • Hold Cadila Healthcare; target of Rs 275: Sharekhan

      Sharekhan recommended Hold rating on Cadila Healthcare with a target price of Rs 275 in its research report dated August 09, 2019.

    • Buy Cadila Health; target of Rs 275: Motilal Oswal

      Motilal Oswal is bullish on Cadila Health has recommended buy rating on the stock with a target price of Rs 275 in its research report dated August 10, 2019.

    • Hold Cadila Healthcare; target of Rs 280: ICICI Direct

      ICICI Direct recommended hold rating on Cadila Healthcare with a target price of Rs 280 in its research report dated May 30, 2019.

    • Buy Cadila Health; target of Rs 345: Motilal Oswal

      Motilal Oswal is bullish on Cadila Health has recommended buy rating on the stock with a target price of Rs 345 in its research report dated May 29, 2019.

    • Hold Cadila Healthcare; target of Rs 290: Sharekhan

      Sharekhan recommended Hold rating on Cadila Healthcare with a target price of Rs 290 in its research report dated May 29, 2019.

    Advisory Alert: It has come to our attention that certain individuals are representing themselves as affiliates of Moneycontrol and soliciting funds on the false promise of assured returns on their investments. We wish to reiterate that Moneycontrol does not solicit funds from investors and neither does it promise any assured returns. In case you are approached by anyone making such claims, please write to us at grievanceofficer@nw18.com or call on 02268882347